138 related articles for article (PubMed ID: 18452463)
1. Improved effects of a double suicide gene system on prostate cancer cells by targeted regulation of prostate-specific membrane antigen promoter and enhancer.
Zhang P; Zeng H; Wei Q; Lu Y; Li X; Wang J; Zhao F; Li H
Int J Urol; 2008 May; 15(5):442-8. PubMed ID: 18452463
[TBL] [Abstract][Full Text] [Related]
2. [Construction and expression of recombinant plasmid with prostate-specific membrane antigen promoter and enhancer regulating uracil phosphoribosyltransferase gene].
Zhao FJ; Li H; Cheng HM; Zeng H; Wei Q; Li X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):172-5. PubMed ID: 15807258
[TBL] [Abstract][Full Text] [Related]
3. Specific targeting of prostate cancer cells in vitro by the suicide gene/prodrug system, uracil phosphoribosyltransferase/5-fluorouracil, under the control of prostate-specific membrane antigen promoter/enhancer.
Zhao FJ; Zhang S; Yu ZM; Xia SJ; Li H
Prostate Cancer Prostatic Dis; 2009; 12(2):166-71. PubMed ID: 18626508
[TBL] [Abstract][Full Text] [Related]
4. Recombinant adenovirus mediated prostate-specific enzyme pro-drug gene therapy regulated by prostate-specific membrane antigen (PSMA) enhancer/promoter.
Zeng H; Wei Q; Huang R; Chen N; Dong Q; Yang Y; Zhou Q
J Androl; 2007; 28(6):827-35. PubMed ID: 17522418
[TBL] [Abstract][Full Text] [Related]
5. [Bystander effect of target-regulated uracil phosphoribosyltransferase/5-fluorouracil suicide gene system on prostate cancer cell].
Zhao FJ; Li H; Zeng H; Wei Q; Li X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):394-7. PubMed ID: 18575323
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy for prostate cancer using the cytosine deaminase/uracil phosphoribosyltransferase suicide system.
Miyagi T; Koshida K; Hori O; Konaka H; Katoh H; Kitagawa Y; Mizokami A; Egawa M; Ogawa S; Hamada H; Namiki M
J Gene Med; 2003 Jan; 5(1):30-7. PubMed ID: 12516049
[TBL] [Abstract][Full Text] [Related]
7. Suicide gene therapy with the yeast fusion gene cytosine deaminase/uracil phosphoribosyltransferase is not enough for pancreatic cancer.
Fogar P; Navaglia F; Basso D; Greco E; Zambon CF; Fadi E; Falda A; Stranges A; Vannozzi F; Danesi R; Pedrazzoli S; Plebani M
Pancreas; 2007 Oct; 35(3):224-31. PubMed ID: 17895842
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific suicide gene therapy using the prostate-specific membrane antigen promoter and enhancer.
O'Keefe DS; Uchida A; Bacich DJ; Watt FB; Martorana A; Molloy PL; Heston WD
Prostate; 2000 Oct; 45(2):149-57. PubMed ID: 11027414
[TBL] [Abstract][Full Text] [Related]
9. Construction of prostate-specific expressed recombinant plasmids with high transcriptional activity of prostate-specific membrane antigen (PSMA) promoter/enhancer.
Zeng H; Wu Q; Li H; Wei Q; Lu Y; Li X; Wang F; Zhao F; Ding Z; Yang Y
J Androl; 2005; 26(2):215-21. PubMed ID: 15713827
[TBL] [Abstract][Full Text] [Related]
10. Tissue-selective RNA interference in prostate cancer cell using prostate specific membrane antigen promoter/enhancer.
Zhao W; Xu Y; Kong D; Liu R; Zhang Z; Jin C; Zhang Z; Xiu Y
Urol Oncol; 2009; 27(5):539-47. PubMed ID: 18639471
[TBL] [Abstract][Full Text] [Related]
11. Cell-selective gene silencing in prostate cancer LNCap cells using prostate-specific membrane antigen promoter and enhancer in vitro and in vivo.
Liu R; Sun J; Zhang Z; Xu Y
Cell Biol Int; 2012 Oct; 36(10):863-72. PubMed ID: 22612256
[TBL] [Abstract][Full Text] [Related]
12. In vivo suicide gene therapy model using a newly discovered prostate-specific membrane antigen promoter/enhancer: a potential alternative approach to androgen deprivation therapy.
Uchida A; O'Keefe DS; Bacich DJ; Molloy PL; Heston WD
Urology; 2001 Aug; 58(2 Suppl 1):132-9. PubMed ID: 11502468
[TBL] [Abstract][Full Text] [Related]
13. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine.
Koyama F; Sawada H; Hirao T; Fujii H; Hamada H; Nakano H
Cancer Gene Ther; 2000 Jul; 7(7):1015-22. PubMed ID: 10917204
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and the bystander effect in CD::UPRT/5-FC bi-gene therapy of glioma.
Shi DZ; Hu WX; Li LX; Chen G; Wei D; Gu PY
Chin Med J (Engl); 2009 Jun; 122(11):1267-72. PubMed ID: 19567135
[TBL] [Abstract][Full Text] [Related]
15. Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicity.
Kaliberov SA; Chiz S; Kaliberova LN; Krendelchtchikova V; Della Manna D; Zhou T; Buchsbaum DJ
Cancer Gene Ther; 2006 Feb; 13(2):203-14. PubMed ID: 16082379
[TBL] [Abstract][Full Text] [Related]
16. [The construction of recombinant plasmid with prostate-specific membrane antigen promoter controlling reporter gene expression].
Zeng H; Li H; Liao YC; Li X; Wu Q; Yang YR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):169-71. PubMed ID: 15807257
[TBL] [Abstract][Full Text] [Related]
17. Experimental gene therapy for brain tumors using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene with 5-fluorocytosine.
Adachi Y; Tamiya T; Ichikawa T; Terada K; Ono Y; Matsumoto K; Furuta T; Hamada H; Ohmoto T
Hum Gene Ther; 2000 Jan; 11(1):77-89. PubMed ID: 10646641
[TBL] [Abstract][Full Text] [Related]
18. [Gene therapy for melanoma by bifidobacterium infantis-mediated transfer of CD and UPRT genes with 5-FC in vitro].
An LN; Li ZH; Yue Y; Wang SR; Guo ZY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):27-30, 63. PubMed ID: 17294721
[TBL] [Abstract][Full Text] [Related]
19. Two-step transcriptional amplification-lipid-based nanoparticles using PSMA or midkine promoter for suicide gene therapy in prostate cancer.
Hattori Y; Maitani Y
Cancer Sci; 2006 Aug; 97(8):787-98. PubMed ID: 16800821
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of the uracil phosphoribosyltransferase gene with a chimeric human nerve growth factor receptor/cytosine deaminase fusion gene, using a single retroviral vector, augments cytotoxicity of transduced human T cells exposed to 5-fluorocytosine.
O'Brien TA; Tuong DT; Basso LM; McIvor RS; Orchard PJ
Hum Gene Ther; 2006 May; 17(5):518-30. PubMed ID: 16716109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
